ES8802046A1 - Un procedimiento para la preparacion de nuevos derivados de tiazolidina. - Google Patents
Un procedimiento para la preparacion de nuevos derivados de tiazolidina.Info
- Publication number
- ES8802046A1 ES8802046A1 ES552502A ES552502A ES8802046A1 ES 8802046 A1 ES8802046 A1 ES 8802046A1 ES 552502 A ES552502 A ES 552502A ES 552502 A ES552502 A ES 552502A ES 8802046 A1 ES8802046 A1 ES 8802046A1
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- thiazolidine derivatives
- blood
- noh
- choh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE TIAZOLIDINA, DE FORMULA GENERAL (I), Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA GENERAL (II), EN LA QUE R1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO; R2 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO C1-5; R3 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALCANOILO O UN GRUPO ALQUENOLILO; Y X REPRESENTA UN ATOMO DE HALOGENO, CON TIOUREA Y EN PRESENCIA DE UN DISOLVENTE QUE NO AFECTE DE MODO ADVERSO A LA REACCION. DE APLICACION TERAPEUTICA PARA REDUCIR LOS NIVELES DE AZUCAR EN LA SANGRE Y DE LOS LIPIDOS EN LA SANGRE.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3532485 | 1985-02-26 | ||
JP3532585 | 1985-02-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8802046A1 true ES8802046A1 (es) | 1988-03-16 |
ES552502A0 ES552502A0 (es) | 1988-03-16 |
Family
ID=26374301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES552502A Expired ES8802046A1 (es) | 1985-02-26 | 1986-02-26 | Un procedimiento para la preparacion de nuevos derivados de tiazolidina. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5104888A (es) |
EP (1) | EP0207581B1 (es) |
KR (1) | KR930003335B1 (es) |
AU (1) | AU588857B2 (es) |
CA (1) | CA1256106A (es) |
DE (1) | DE3674089D1 (es) |
DK (1) | DK173350B1 (es) |
ES (1) | ES8802046A1 (es) |
FI (1) | FI82693C (es) |
IE (1) | IE58853B1 (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4873255A (en) * | 1987-02-04 | 1989-10-10 | Sankyo Company Limited | Thiazolidinone derivatives, their preparation and their use |
US5015661A (en) * | 1988-08-09 | 1991-05-14 | Hoffmann-La Roche Inc. | Chromanes and their pharmaceutical compositions and methods |
GB8919417D0 (en) | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
JP2826379B2 (ja) * | 1990-01-22 | 1998-11-18 | 三共株式会社 | チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤 |
GB9023584D0 (en) * | 1990-10-30 | 1990-12-12 | Beecham Group Plc | Novel compounds |
FR2680512B1 (fr) * | 1991-08-20 | 1995-01-20 | Adir | Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
GB9124513D0 (en) * | 1991-11-19 | 1992-01-08 | Smithkline Beecham Plc | Novel process |
CA2082003A1 (en) * | 1991-11-20 | 1993-05-21 | David Laffan | Process for the preparation of substituted pentaalkylchromenes |
CA2089013A1 (en) * | 1992-02-21 | 1993-08-22 | Josef Heveling | Process for the preparation of 6-hydroxy-2, 5, 7, 8- tetraalkyl-2-(4-aminophenoxymethyl) chromans |
CA2089012A1 (en) * | 1992-02-21 | 1993-08-22 | Josef Heveling | Process for the preparation of 6-hydroxy-2,5,7,8-tetra- alkyl-2-(4-aminophenoxymethyl) chromans |
FR2696743B1 (fr) * | 1992-10-12 | 1994-12-23 | Adir | Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
JP2845743B2 (ja) * | 1992-12-28 | 1999-01-13 | 三菱化学株式会社 | 新規なナフタレン誘導体 |
US5594016A (en) * | 1992-12-28 | 1997-01-14 | Mitsubishi Chemical Corporation | Naphthalene derivatives |
WO1994019347A1 (en) * | 1993-02-24 | 1994-09-01 | Sankyo Company, Limited | Arteriosclerosis remedy |
USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
CZ289317B6 (cs) * | 1994-04-11 | 2002-01-16 | Sankyo Company Limited | Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití |
JP3871354B2 (ja) * | 1994-07-29 | 2007-01-24 | 株式会社フジモト・コーポレーション | 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体 |
CA2159938A1 (en) * | 1994-10-07 | 1996-04-08 | Hiroaki Yanagisawa | Oxime derivatives, their preparation and their therapeutic use |
IL118474A (en) * | 1995-06-01 | 2001-08-08 | Sankyo Co | Benzimideol derivatives and pharmaceutical preparations containing them |
US5919782A (en) * | 1996-05-06 | 1999-07-06 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
US5801173A (en) * | 1996-05-06 | 1998-09-01 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
ZA973848B (en) * | 1996-05-06 | 1997-12-02 | Reddy Research Foundation | Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them. |
US5889025A (en) * | 1996-05-06 | 1999-03-30 | Reddy's Research Foundation | Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
DE19619819A1 (de) * | 1996-05-16 | 1997-11-20 | Boehringer Mannheim Gmbh | Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltenden Arzneimittel |
US6372750B2 (en) | 1996-07-01 | 2002-04-16 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases |
CZ298812B6 (cs) | 1996-07-01 | 2008-02-13 | Dr. Reddy's Laboratories Limited | Azolidindionové deriváty, způsob jejich přípravy, farmaceutické kompozice s jejich obsahem a jejich použití v léčbě diabetu a příbuzných nemocí |
USRE39266E1 (en) * | 1996-07-01 | 2006-09-05 | Dr. Reddy's Laboratories, Limited | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
US5885997A (en) * | 1996-07-01 | 1999-03-23 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
US6114526A (en) * | 1996-07-01 | 2000-09-05 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
FR2760748A1 (fr) * | 1997-03-14 | 1998-09-18 | Rhodia Chimie Sa | Procede de preparation de 2h-1-benzopyranes |
UA67743C2 (uk) | 1997-06-18 | 2004-07-15 | Смітклайн Бічам П.Л.С. | Фармацевтична композиція, що містить тіазолідиндіон і сульфонілсечовину, для лікування діабету |
FR2766820B1 (fr) * | 1997-07-31 | 1999-10-22 | Rhodia Chimie Sa | Procede de preparation de 2h-1-benzopyranes et intermediaires de synthese utiles dans la mise en oeuvre du procede |
AU749505B2 (en) * | 1997-10-27 | 2002-06-27 | Dr. Reddy's Laboratories Limited | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
US6444816B1 (en) | 1997-10-27 | 2002-09-03 | Dr. Reddy's Research Foundation | Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof |
BR9812770A (pt) | 1997-10-27 | 2000-12-12 | Reddy Research Foundation | Compostos bicìclicos, processo para seu preparo e composições farmacêuticas contendo os mesmos |
US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
EP1124807A1 (en) | 1997-10-27 | 2001-08-22 | Dr. Reddy's Research Foundation | Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
US6369067B1 (en) | 1997-10-27 | 2002-04-09 | Dr. Reddy's Research Foundation | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
US6265401B1 (en) | 1997-10-27 | 2001-07-24 | Reddy-Cheminor, Inc. | Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
CN100357281C (zh) * | 1998-05-27 | 2007-12-26 | 雷迪实验室有限公司 | 双环化合物、其制备方法和包含它们的药物组合物 |
AR023699A1 (es) | 1998-11-12 | 2002-09-04 | Smithkline Beecham Corp | Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica |
NZ511614A (en) | 1998-11-12 | 2003-12-19 | Smithkline Beecham P | Modified release pharmaceutical composition containing the insulin sensitiser 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and the antidiabetic agent metaformin |
NZ515284A (en) * | 1999-04-28 | 2004-12-24 | Dr | Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
AU6016200A (en) * | 1999-07-16 | 2001-02-05 | Sankyo Company Limited | Coumarone analogues |
GB0014969D0 (en) | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
US8216609B2 (en) * | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
US8268352B2 (en) * | 2002-08-05 | 2012-09-18 | Torrent Pharmaceuticals Limited | Modified release composition for highly soluble drugs |
US20080207711A1 (en) * | 2007-02-28 | 2008-08-28 | Rong Li | Method for treating an ID2-related disorder |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
CN102325783A (zh) | 2008-12-23 | 2012-01-18 | 法莫赛特股份有限公司 | 嘌呤核苷的合成 |
PA8855601A1 (es) | 2008-12-23 | 2010-07-27 | Forformidatos de nucleósidos | |
CA2748034A1 (en) * | 2008-12-23 | 2010-07-01 | Pharmasset, Inc. | Purified 2'-deoxy'2'-fluoro-2'-c-methyl-nucleoside-phosphoramidate prodrugs for the treatment of viral infections |
CA2766033C (en) * | 2009-06-25 | 2016-09-20 | Alkermes, Inc. | Prodrugs of nh-acidic compounds |
US10429384B2 (en) | 2010-01-22 | 2019-10-01 | Dana-Farber Cancer Institute, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders |
SG184323A1 (en) | 2010-03-31 | 2012-11-29 | Gilead Pharmasett Llc | Stereoselective synthesis of phosphorus containing actives |
CA2890086C (en) | 2012-11-05 | 2022-05-31 | Commissariat A L'energie Atomique Et Aux Energies Alternatives (Cea) | Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a stat5 antagonist preferably a thiazolid nedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse |
WO2016071727A1 (en) | 2014-11-04 | 2016-05-12 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the prevention and the treatment of rapidly progressive glomerulonephritis |
CA3092335A1 (en) | 2018-03-05 | 2019-09-12 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH619701A5 (es) | 1975-08-07 | 1980-10-15 | Bayer Ag | |
JPS5522636A (en) | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
DE3010504A1 (de) | 1980-03-19 | 1981-10-01 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von 2-hydroxyalkylchromanen |
JPS58118577A (ja) * | 1982-01-07 | 1983-07-14 | Takeda Chem Ind Ltd | チアゾリジン誘導体 |
JPS58201775A (ja) | 1982-05-17 | 1983-11-24 | Kuraray Co Ltd | 3,4−ジヒドロ−2h−ベンゾピラン誘導体の製造方法 |
PT79094B (en) * | 1983-08-29 | 1986-08-14 | Salk Inst For Biological Studi | Grf analogs |
JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
JPS6136284A (ja) * | 1984-07-27 | 1986-02-20 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造方法 |
-
1986
- 1986-02-25 DK DK198600878A patent/DK173350B1/da not_active IP Right Cessation
- 1986-02-26 CA CA000502816A patent/CA1256106A/en not_active Expired
- 1986-02-26 EP EP86301398A patent/EP0207581B1/en not_active Expired - Lifetime
- 1986-02-26 DE DE8686301398T patent/DE3674089D1/de not_active Expired - Fee Related
- 1986-02-26 IE IE51286A patent/IE58853B1/en not_active IP Right Cessation
- 1986-02-26 FI FI860832A patent/FI82693C/fi not_active IP Right Cessation
- 1986-02-26 ES ES552502A patent/ES8802046A1/es not_active Expired
- 1986-02-26 AU AU54122/86A patent/AU588857B2/en not_active Ceased
- 1986-02-26 KR KR1019860001352A patent/KR930003335B1/ko not_active IP Right Cessation
-
1990
- 1990-07-25 US US07/560,466 patent/US5104888A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI82693C (fi) | 1991-04-10 |
AU588857B2 (en) | 1989-09-28 |
FI82693B (fi) | 1990-12-31 |
FI860832A0 (fi) | 1986-02-26 |
AU5412286A (en) | 1986-09-04 |
EP0207581B1 (en) | 1990-09-12 |
DK87886D0 (da) | 1986-02-25 |
US5104888A (en) | 1992-04-14 |
KR860006458A (ko) | 1986-09-11 |
IE58853B1 (en) | 1993-11-17 |
IE860512L (en) | 1986-08-26 |
ES552502A0 (es) | 1988-03-16 |
FI860832A (fi) | 1986-08-27 |
CA1256106A (en) | 1989-06-20 |
DK87886A (da) | 1986-08-27 |
KR930003335B1 (ko) | 1993-04-26 |
EP0207581A2 (en) | 1987-01-07 |
DE3674089D1 (de) | 1990-10-18 |
DK173350B1 (da) | 2000-08-07 |
EP0207581A3 (en) | 1987-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8802046A1 (es) | Un procedimiento para la preparacion de nuevos derivados de tiazolidina. | |
IE880301L (en) | Thiazolidinone derivatives, their preparation and their use | |
DK341187D0 (da) | Virucidt middel med bredspekret virkning | |
ES8802155A1 (es) | Procedimiento para preparar derivados de imidazo(1,5-a)piridina | |
ATE90345T1 (de) | Bis-naphthalimide, ihre herstellung und verwendung. | |
AU580391B2 (en) | Cyclopental ``d``pyrimidine derivatives, their preparation and use | |
DE3270118D1 (en) | 6-alpha-methyl-prednisolone derivatives, their preparation and utilization | |
NO851680L (no) | Fremgangsmaate for fremstilling av fysiologisk aktive fenol-derivater. | |
ES2059755T3 (es) | Derivados organicos de hidrazina para uso farmaceutico. | |
SE8703032D0 (es) | ||
ES8701193A1 (es) | Un procedimiento para preparar derivados de acido griseolico | |
FR2451191A1 (fr) | Compositions therapeutiques a base de derives hydroxyles de l'isopropylamino-2 pyrimidine | |
KR890014112A (ko) | 퀴놀리진 및 퀴놀리지논 유도체의 심장 부정맥 치료용 의약품 제조에 있어서의 용도 | |
NO167865C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 14,17beta-ethano-14beta-oestratrienderivater. | |
ES2002207A6 (es) | Un metodo para producir derivados de glucosilmoranolina | |
ES553207A0 (es) | Un procedimiento para la preparacion de una octahidroindolizina | |
AU558461B2 (en) | Carbamyloxybenzhyrol derivatives | |
NO870423L (no) | 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter. | |
ATE64921T1 (de) | Benzochinonderivate, ihre herstellung und verwendung. | |
ES482152A1 (es) | Un procedimiento para la preparacion de nuevas 3-fenilpro- pilaminas n-sustituidas. | |
DE3160851D1 (en) | Lidocaine derivative and therapeutic compositions which contain it as their active principle | |
Neville | Reconstruction of Thinking | |
SE8200248L (sv) | Nya apovinkaminolderivat | |
ES8105250A1 (es) | Un procedimiento para la preparacion de decalinas sustitui- das. | |
AU6243586A (en) | Naphthalene "ester" anti-psoriatic agents |